Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2018-07-31 | 2018-07-31 |
| Drug Identification Number | 02303094 | 02303094 |
| Brand name | HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) | HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) |
| Common or Proper name | HEPARIN Na Inj 10,000U/mL 10x1mLV | HEPARIN Na Inj 10,000U/mL 10x1mLV |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | HEPARIN SODIUM | HEPARIN SODIUM |
| Strength(s) | 10000UNIT | 10000UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS SUBCUTANEOUS | INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 10 X 1mL Vials | 10 X 1mL Vials |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | 2018-07-30 | 2018-07-30 |
| Actual discontinuation date | 2018-07-30 | 2018-07-30 |
| Remaining supply date | 2018-07-04 | 2018-07-04 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | ||
| Health Canada comments |